Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation

J Biol Chem. 2001 Mar 30;276(13):9978-84. doi: 10.1074/jbc.M002285200. Epub 2000 Dec 21.

Abstract

Androgen receptor (AR) may communicate with the general transcription machinery on the core promoter to exert its function as a transcriptional modulator. Our previous report demonstrated that the AR interacted with transcription factor IIH (TFIIH) under physiological conditions and that overexpression of Cdk-activating kinase, the kinase moiety of TFIIH, enhanced AR-mediated transcription in prostate cancer cells. In an effort to further dissect the mechanisms implicated in AR transactivation, we report here that AR interacts with PITALRE, a kinase subunit of positive elongation factor b (P-TEFb). Cotransfection of the plasmid encoding the mutant PITALRE (mtPITALRE), defective in its RNA polymerase II COOH-terminal domain (CTD)-kinase activity, resulted in preferential inhibition of AR-mediated transactivation. Indeed, AR transactivation in PC-3 cells was preferentially inhibited at the low concentration of 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB), a CTD kinase inhibitor. These results suggest that CTD phosphorylation may play an important role in AR-mediated transcription. Furthermore, a nuclear run-on transcription assay of the prostate-specific antigen gene, an androgen-inducible gene, showed that transcription efficiency of the distal region of the gene was enhanced upon androgen induction. Taken together, our reports suggest that AR interacts with TFIIH and P-TEFb and enhances the elongation stage of transcription.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Line
  • Cell Nucleus / metabolism
  • Cyclin-Dependent Kinase 9
  • Cyclin-Dependent Kinases / metabolism
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Ligands
  • Male
  • Models, Biological
  • Mutation
  • Plasmids / metabolism
  • Positive Transcriptional Elongation Factor B
  • Precipitin Tests
  • Prostate-Specific Antigen / genetics
  • Prostatic Neoplasms / metabolism
  • Protein Binding
  • Protein Serine-Threonine Kinases / genetics*
  • Protein Serine-Threonine Kinases / metabolism*
  • Protein Structure, Tertiary
  • Receptors, Androgen / metabolism*
  • Transcription Factor TFIIH
  • Transcription Factors / metabolism
  • Transcription Factors, TFII*
  • Transcription, Genetic*
  • Transcriptional Activation
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Enzyme Inhibitors
  • Ligands
  • Receptors, Androgen
  • Transcription Factors
  • Transcription Factors, TFII
  • Transcription Factor TFIIH
  • Dichlororibofuranosylbenzimidazole
  • Positive Transcriptional Elongation Factor B
  • Protein Serine-Threonine Kinases
  • CDK9 protein, human
  • Cyclin-Dependent Kinase 9
  • Cyclin-Dependent Kinases
  • Prostate-Specific Antigen